Adeona Pharmaceuticals, a pharmaceutical company developing new medicines for serious central nervous systems diseases, has appointed Julie Caudill vice president of finance and corporate controller. Caudill brings to Adeona more than 15 years of biotechnology-related accounting and Securities and Exchange Commission compliance experience.

Learn More
Already a member? Sign in to an existing account.

Jaclyn Jaeger is a freelance contributor to Compliance Week after working for the company for 15 years. She writes on a wide variety of topics, including ethics and compliance, risk management, legal,...